2017 American Transplant Congress » Poster Session C: PTLD/Malignancies

6:00pm-7:00pm

10 Years of DTAC Experience with Kaposi's Sarcoma – Not Just Another PTLD!

M. Nalesnik,¹ M. Clark,² S. Tlusty,² M. Michaels,¹ C. Wolfe.¹

6:00pm-7:00pm

In Depth Characterization of the Innate Immune Response in Transplant Recipients with EBV Viremia.

V. Ferreira, J. Batist, D. Kumar, S. Husain, A. Humar.

6:00pm-7:00pm

Incidence, Recurrence and Long Term Survival Post Chemotherapy in Renal Transplant Recipients with Post Transplant Lymphoproliferative Disorder: Single Center Study.

R. Rathore, K. Tomlinson, H. Dukka, D. Farrugia, M. Lambie.

6:00pm-7:00pm

Long-Term Malignancy Risk in Kidney Transplant Recipients Treated with Cyclophosphamide Pre-Transplant for Native Glomerular Disease.

J. Mills,¹ M. Jorgenson,¹ J. Fose,¹ B. Astor,² S. Panzer.²

6:00pm-7:00pm

Lymphoproliferative Disorders After Renal Transplantation Along Two Decades: A Large Longitudinal Study.

A. Franco,¹ D. Hernandez,² N. Maruri,³ A. Alonso,⁴ M. Crespo,⁵ A. Mazuecos,⁶ C. Diaz-Corte,⁷ M. Gentil.⁸

6:00pm-7:00pm

Predictors of Malignancies Across Solid Organ Transplantation.

M. Bhat,¹ K. Mara,² R. Dierkhising,² K. Watt.³

6:00pm-7:00pm

Significance of Atypical Cytology in the Evaluation of Patients with End Stage Renal Disease for Transplantation.

J. Law, O. Ali, H. Brar, P. Luke, A. Sener.

6:00pm-7:00pm

The Effiency and Safety of Chemotherapy for Urothelial Carcinoma in Post-Kidney Transplanted Patients.

Y. Zhu, J. Lin.